Lower circulating endocannabinoid levels in children with autism spectrum disorder
Abstract Background The endocannabinoid system (ECS) is a major regulator of synaptic plasticity and neuromodulation. Alterations of the ECS have been demonstrated in several animal models of autism spectrum disorder (ASD). In some of these models, activating the ECS rescued the social deficits. Evi...
Main Authors: | Adi Aran, Maya Eylon, Moria Harel, Lola Polianski, Alina Nemirovski, Sigal Tepper, Aviad Schnapp, Hanoch Cassuto, Nadia Wattad, Joseph Tam |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Molecular Autism |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13229-019-0256-6 |
Similar Items
-
Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study
by: Elettra Febo, et al.
Published: (2021-05-01) -
The effects of exercise on circulating endocannabinoid levels—a protocol for a systematic review and meta-analysis
by: Viviane Bristot, et al.
Published: (2022-05-01) -
The endocannabinoid system: an overview
by: Natalia eBattista, et al.
Published: (2012-03-01) -
Circulating endocannabinoid levels in pregnant women with gestational diabetes mellitus: a case–control study
by: Hadi Bazyar, et al.
Published: (2022-11-01) -
Endocannabinoids, Related Compounds and Their Metabolic Routes
by: Filomena Fezza, et al.
Published: (2014-10-01)